CANAGLIFLOZIN for Diabetes mellitus inadequate control: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 121 adverse event reports in the FDA FAERS database where CANAGLIFLOZIN was used for Diabetes mellitus inadequate control.
Most Reported Side Effects for CANAGLIFLOZIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diabetic ketoacidosis | 3,413 | 14.0% | 67 | 2,837 |
| Toe amputation | 2,193 | 9.0% | 19 | 1,647 |
| Osteomyelitis | 2,146 | 8.8% | 20 | 1,807 |
| Acute kidney injury | 1,853 | 7.6% | 69 | 1,595 |
| Fungal infection | 1,385 | 5.7% | 3 | 63 |
| Gangrene | 1,081 | 4.4% | 14 | 952 |
| Weight decreased | 1,014 | 4.2% | 13 | 150 |
| Cellulitis | 1,007 | 4.1% | 9 | 887 |
| Urinary tract infection | 920 | 3.8% | 16 | 318 |
| Diabetic foot infection | 832 | 3.4% | 8 | 755 |
| Leg amputation | 792 | 3.2% | 23 | 668 |
| Diabetic foot | 787 | 3.2% | 9 | 663 |
| Blood glucose increased | 777 | 3.2% | 6 | 162 |
| Off label use | 724 | 3.0% | 15 | 272 |
| Ketoacidosis | 641 | 2.6% | 11 | 272 |
Other Indications for CANAGLIFLOZIN
Type 2 diabetes mellitus (10,795)
Product used for unknown indication (8,748)
Diabetes mellitus (3,397)
Type 1 diabetes mellitus (422)
Diabetes mellitus management (257)
Blood glucose increased (85)
Glycosylated haemoglobin increased (55)
Weight decreased (46)
Blood glucose abnormal (39)
Hyperglycaemia (35)
Other Drugs Used for Diabetes mellitus inadequate control
SEMAGLUTIDE (98)
EXENATIDE (74)
EMPAGLIFLOZIN (73)
INSULIN LISPRO (72)
LIRAGLUTIDE (66)
DULAGLUTIDE (65)
INSULIN ASPART (63)
INSULIN GLARGINE (54)
INSULIN HUMAN (43)
METFORMIN (42)